Clinical study of different adsorbents with dual plasma molecular adsorption system in the treatment of hepatic failure
10.3760/cma.j.issn.1007-3418.2019.01.011
- VernacularTitle: 不同吸附剂在双重血浆分子吸附系统治疗肝衰竭中的临床研究
- Author:
Guosheng YAN
1
;
Lili LI
;
Shaoli JIANG
;
Song MENG
;
Chenchen WU
Author Information
1. Department of Blood Purification, the Sixth People's Hospital of Zhengzhou, Zhengzhou 450000, China
- Publication Type:Journal Article
- Keywords:
Liver, artificial;
Thrapy;
Liver failure;
Double plasma molecular absorb syetem;
active charcoal
- From:
Chinese Journal of Hepatology
2019;27(1):51-55
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To investigate the effects of two different sorbents(Carbon perfusion apparatus and Resin perfusion apparatus)in Double plasma molecular absorb syetem for liver failure treatment.
Methods:A total of 152 cases with liver failure who were admitted to The Sixth People's Hospital of Zhengzhou, from June 2016 to May 2018 were selected and divided into DPMARS Carbon group (77 cases) and Resin group (75 cases). The two groups were observed in terms of liver function, prothrombin activity(PTA),Plasma albumin ,tumor necrosis factor alpha and interleukin-6 were detected and compared between the two groups before and after treatment.
Results:①The clinical symptoms improved in different degree in two groups, the recovery rate of Carbon cans Carbon perfusion apparatus group and Resin group separately were89.6% (69/77)、90.7% (68/75)(χ2 = 0.048, P = 0.975), there were no statistical differences. There were no statistical differences between the two groups in untoward reactions(χ2 = 0.235, P = 0.995), ②Compared with before treatment, TBil(t = 3.735, 3.728; P = 0.000, 0.000)、ALT(t = 5.117, 5.203; P = 0.000, 0.000)、TNF-α (t = 3.158, 3.094; P = 0.000, 0.002)、IL-6(t = 3.647, 3.559; P = 0.002, 0.003)decreased and ALB (t = 2.300, 3.065; P = 0.024, 0.003) increased significantly after treatment in both groups, and there were statistical differences. There were no signifiant differences in the changes in ALB(t = 0.316, 0.209; P = 0.657, 0.720) and PTA(t = 0.810, 0.843; P = 0.429, 0.516). ③After treatment, there were no signifiant differences in the changes in TBil、ALT、ALB、PTA、TNF-α、IL-6(t = 0.377、0.904、-1.133、-1.552、0.841、0.401; P = 0.952、0.283、0.826、0.094、0.154、0.457).
Conclusion:Double plasma molecular absorb syetem is effective in treating liver failure. Carbon perfusion apparatus or Resin perfusion apparatus can be combined with Specific bilirubin adsorption column for DPMARS in clinical treatment,and their effects are similar.
